Home » Topics » BioWorld Science

BioWorld Science
RSS

Batavia collaborates with RocketVax on SARS-CoV-2 vaccine candidate

July 8, 2021

Ysopia completes phase I study of Xla-1 for obesity and metabolic diseases

July 8, 2021

Alterations in GRK5 disrupt cardiac function in murine model

July 8, 2021

Ischemix awarded DoD funding to support phase I study of CMX-2043 for traumatic brain injury

July 8, 2021

AXA-1125 enhances insulin sensitivity in subjects with NAFLD and T2D

July 8, 2021

FDA clears IND for ASC-618 gene therapy for hemophilia A

July 8, 2021

Dosing starts in phase I/II study of Moderna's quadrivalent seasonal flu mRNA vaccine

July 8, 2021

Atossa receives approval to open phase I/II study of AT-H201 in Australia

July 8, 2021

CXD-101 demonstrates promising early clinical data in its China IND program

July 8, 2021

LY-3305677 is safe and shows body weight-lowering effect in FIH trial

July 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026